County
Grant County
Drugs and doses45
A–C Acetaminophen, Activated Charcoal, Adenosine, Albuterol, Amiodarone, Atropine, Calcium Chloride, Calcium Gluconate8
Acetaminophen
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Fever | adult | 15 mg/kg | IV | not captured | standing | page 3 |
| Fever | peds | 10–15 mg/kg | PO | not captured | standing | page 3 |
| Mild to moderate pain | adult | 1000 mg | IV | not captured | standing | page 3 |
| Mild to moderate pain | peds | 15 mg/kg | IV | not captured | standing | page 3 |
Activated Charcoal
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1 g/kg | PO | not captured | standing | page 5 |
| Other | peds | 1 g/kg | PO | not captured | standing | page 5 |
Adenosine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 6 mg | IV/IO | not captured | standing | page 6 |
| Other | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 6 |
Albuterol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 2.5–5 mg | NEB | not captured | standing | page 8 |
| Other | peds | 1.25–2.5 mg | NEB | not captured | standing | page 8 |
Amiodarone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 150 mg | IV/IO | not captured | standing | pages 9, 10 |
| Other | adult | 300 mg | IV/IO | not captured | standing | pages 9, 10 |
| Other | peds | 5 mg/kg | IV/IO | not captured | standing | pages 9, 10 |
| Other | peds | 5 mg/kg | IV/IO | not captured | standing | pages 9, 10 |
Atropine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1 mg | IV/IO | not captured | standing | page 16 |
| Other | adult | 1–2 mg | IV/IO/IM | not captured | standing | page 16 |
| Other | adult | 2 mg | IV | not captured | standing | page 16 |
| Other | peds | 0.02 mg/kg | IV/IO | not captured | standing | page 16 |
| Other | peds | 0.05 mg/kg | IV/IO/IM | not captured | standing | page 16 |
Calcium Chloride
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 5–10 mL | IV | not captured | standing | page 26 |
| Beta-blocker / calcium-channel-blocker overdose | peds | 0.2 mL/kg | IV | not captured | standing | page 26 |
| Other | adult | 5–10 mL | IV | not captured | standing | page 26 |
| Other | adult | 5–10 mL | IV | not captured | standing | page 26 |
| Other | adult | 5–10 mL | IV | not captured | standing | page 26 |
| Other | adult | 5–10 mL | IV | not captured | standing | page 26 |
| Other | adult | 5–10 mL | IV | not captured | standing | page 26 |
| Other | peds | 0.2 mL/kg | IV | not captured | standing | page 26 |
| Other | peds | 0.2 mL/kg | IV | not captured | standing | page 26 |
| Other | peds | 0.2 mL/kg | IV | not captured | standing | page 26 |
| Other | peds | 0.2 mL/kg | IV | not captured | standing | page 26 |
| Other | peds | 0.2 mL/kg | IV | not captured | standing | page 26 |
Calcium Gluconate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 5–10 mL | IV | not captured | standing | page 26 |
| Beta-blocker / calcium-channel-blocker overdose | peds | 0.6 mL/kg | IV | not captured | standing | page 26 |
| Other | adult | 5–10 mL | IV | not captured | standing | page 26 |
| Other | adult | 5–10 mL | IV | not captured | standing | page 26 |
| Other | adult | 5–10 mL | IV | not captured | standing | page 26 |
| Other | adult | 5–10 mL | IV | not captured | standing | page 26 |
| Other | adult | 5–10 mL | IV | not captured | standing | page 26 |
| Other | peds | 0.6 mL/kg | IV | not captured | standing | page 26 |
| Other | peds | 0.6 mL/kg | IV | not captured | standing | page 26 |
| Other | peds | 0.6 mL/kg | IV | not captured | standing | page 26 |
| Other | peds | 0.6 mL/kg | IV | not captured | standing | page 26 |
| Other | peds | 0.6 mL/kg | IV | not captured | standing | page 26 |
D–F Dexamethasone, Dextrose, Diazepam, Diltiazem, Diphenhydramine, Dobutamine, Dopamine, Epinephrine, Fentanyl, Furosemide10
Dexamethasone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 10 mg | IV/IO/IM | not captured | standing | page 27 |
| Other | adult | 10 mg | IV/IO/IM | not captured | standing | page 27 |
| Other | adult | 10 mg | IV/IO/IM | not captured | standing | page 27 |
| Other | adult | 10 mg | IV/IO/IM | not captured | standing | page 27 |
| Other | peds | 0.6 mg/kg | IV/IO/IM | not captured | standing | page 27 |
| Other | peds | 0.6 mg/kg | IV/IO/IM | not captured | standing | page 27 |
| Other | peds | 0.6 mg/kg | IV/IO/IM | not captured | standing | page 27 |
| Other | peds | 0.6 mg/kg | IV/IO/IM | not captured | standing | page 27 |
Dextrose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 12–25 g | PO | not captured | standing | page 30 |
| Hypoglycemia | adult | 12.5–25 g | IV/IO | not captured | standing | page 30 |
| Hypoglycemia | peds | 0.5–1 g/kg | IV/IO | not captured | standing | page 30 |
| Other | adult | 12.5–25 g | IV/IO | not captured | standing | page 30 |
| Other | adult | 12.5–25 g | IV/IO | not captured | standing | page 30 |
| Other | peds | 0.5–1 g/kg | IV/IO | not captured | standing | page 30 |
| Other | peds | 0.5–1 g/kg | IV/IO | not captured | standing | page 30 |
Diazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 2–10 mg | IV/IO/IM | not captured | standing | page 23 |
| Other | adult | 2–10 mg | IV/IO/IM | not captured | standing | page 23 |
Diltiazem
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Atrial fibrillation with RVR | adult | 10 mg | IV | not captured | standing | page 33 |
| Narrow-complex tachycardia | adult | 0.25 mg/kg | IV | not captured | standing | page 32 |
Diphenhydramine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 25 mg | IV/IO/IM | not captured | standing | page 34 |
| Allergic reaction | peds | 1 mg/kg | IV/IO/IM | not captured | standing | page 34 |
| Anaphylaxis | adult | 25 mg | IV/IO/IM | not captured | standing | page 34 |
| Anaphylaxis | peds | 1 mg/kg | IV/IO/IM | not captured | standing | page 34 |
| Other | adult | 25 mg | IV/IO/IM | not captured | standing | page 34 |
| Other | adult | 25 mg | IV/IO/IM | not captured | standing | page 34 |
| Other | peds | 1 mg/kg | IV/IO/IM | not captured | standing | page 34 |
| Other | peds | 1 mg/kg | IV/IO/IM | not captured | standing | page 34 |
Dobutamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiogenic shock | adult | 2–20 mcg/kg | IV | not captured | standing | page 35 |
| Cardiogenic shock | peds | 1 mcg/kg | IV | not captured | standing | page 35 |
Dopamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypotension / shock | adult | 5–20 mcg/kg | IV | not captured | standing | pages 68, 69 |
| Hypotension / shock | peds | 1 mcg/kg | IV | not captured | standing | pages 68, 69 |
| Other | adult | 5–20 mcg/kg | IV | not captured | standing | page 68 |
| Other | peds | 1 mcg/kg | IV | not captured | standing | page 68 |
Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 0.3–0.5 mg | IM | not captured | standing | page 37 |
| Anaphylaxis | peds | 0.01 mg/kg | IM | not captured | standing | page 37 |
| Asthma / bronchospasm | adult | 0.3–0.5 mg | IM | not captured | standing | page 37 |
| Asthma / bronchospasm | peds | 0.01 mg/kg | IM | not captured | standing | page 37 |
| Cardiac arrest | adult | 1 mg | IV/IO | not captured | standing | page 37 |
| Cardiac arrest | peds | 0.01 mg/kg | IV/IO | not captured | standing | page 37 |
| Croup | peds | 5 mL | NEB | not captured | standing | page 37 |
Fentanyl
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 1 mcg/kg | IV/IO/IM/IN | not captured | standing | pages 51, 52, 82, 109 |
| Mild to moderate pain | peds | 2–3 mcg/kg | IV/IO/IM/IN | not captured | standing | pages 51, 52, 82, 109 |
| RSI induction | adult | 3 mcg/kg | IV/IO | not captured | standing | page 52 |
Furosemide
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| CHF / pulmonary edema | adult | 20–40 mg | IV/IO | not captured | standing | pages 38, 39 |
| CHF / pulmonary edema | peds | 1 mg/kg | IV/IO | not captured | standing | pages 38, 39 |
| Other | adult | 20–40 mg | IV/IO | not captured | standing | pages 38, 39 |
| Other | peds | 1 mg/kg | IV/IO | not captured | standing | pages 38, 39 |
G–L Glucagon, Hydroxocobalamin, Ipratropium, Ketamine, Ketorolac, Labetalol, Levalbuterol, Lidocaine, Lorazepam9
Glucagon
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 1–2 mg | IV/IO | not captured | standing | page 41 |
| Anaphylaxis | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 41 |
| Beta-blocker / calcium-channel-blocker overdose | adult | 3–10 mg | IV/IO | not captured | standing | page 40 |
| Beta-blocker / calcium-channel-blocker overdose | adult | 3–10 mg | IV/IO | not captured | standing | page 40 |
| Beta-blocker / calcium-channel-blocker overdose | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 40 |
| Beta-blocker / calcium-channel-blocker overdose | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 40 |
| Hypoglycemia | adult | 0.5–1 mg | IM/IN | not captured | standing | page 40 |
| Hypoglycemia | peds | 0.1 mg/kg | IM/IN | not captured | standing | page 40 |
Hydroxocobalamin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cyanide poisoning | adult | 5 g | IV/IO | not captured | standing | page 112 |
| Cyanide poisoning | peds | 70 mg/kg | IV/IO | not captured | standing | page 112 |
Ipratropium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 250–500 mcg | NEB | not captured | standing | page 42 |
| COPD | adult | 250–500 mcg | NEB | not captured | standing | page 42 |
| Other | adult | 250–500 mcg | NEB | not captured | standing | page 42 |
Ketamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 2–4 mg/kg | IM | not captured | standing | pages 43, 96 |
| Mild to moderate pain | adult | 0.1–0.5 mg/kg | IV | not captured | standing | page 43 |
| Mild to moderate pain | peds | 0.1–0.5 mg/kg | IV | not captured | standing | page 43 |
| RSI induction | adult | 1–2 mg/kg | IV | not captured | standing | pages 43, 113 |
Ketorolac
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 10–15 mg | IV | not captured | standing | pages 66, 109 |
| Other | adult | 30 mg | IM | not captured | standing | pages 66, 109 |
| Other | peds | 0.5 mg/kg | IV | not captured | standing | pages 66, 109 |
| Other | peds | 0.5 mg/kg | IM | not captured | standing | pages 66, 109 |
Labetalol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 10–20 mg | IV | not captured | standing | page 19 |
| Other | adult | 10–20 mg | IV | not captured | standing | page 19 |
Levalbuterol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 1.25 mg | NEB | not captured | standing | pages 45, 119 |
| Asthma / bronchospasm | peds | 0.63–1.25 mg | NEB | not captured | standing | pages 45, 119 |
Lidocaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1–1.5 mg/kg | IV/IO | not captured | standing | page 46 |
| Other | adult | 40 mg | IO | not captured | standing | page 47 |
| Other | peds | 0.5 mg/kg | IO | not captured | standing | page 47 |
| VF / pulseless VT | adult | 1–1.5 mg/kg | IV/IO | not captured | standing | pages 46, 47 |
| VF / pulseless VT | peds | 1 mg/kg | IV/IO | not captured | standing | pages 46, 47 |
Lorazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 2–4 mg | IV/IO | not captured | standing | page 24 |
| Other | adult | 2–4 mg | IV/IO | not captured | standing | page 24 |
| Other | adult | 2–4 mg | IV/IO | not captured | standing | page 24 |
| Other | peds | 0.05–0.1 mg/kg | IV/IO | not captured | standing | page 24 |
| Other | peds | 0.05–0.1 mg/kg | IV/IO | not captured | standing | page 24 |
| Other | peds | 0.05–0.1 mg/kg | IV/IO | not captured | standing | page 24 |
| Post-intubation sedation | adult | 2–4 mg | IV/IO | not captured | standing | page 24 |
| Post-intubation sedation | peds | 0.05–0.1 mg/kg | IV/IO | not captured | standing | page 24 |
M–O Magnesium Sulfate, Methylprednisolone, Metoprolol, Midazolam, Morphine, Naloxone, Nitroglycerin, Norepinephrine, Olanzapine, Ondansetron10
Magnesium Sulfate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 1–2 g | IV | not captured | standing | pages 48, 119, 144 |
| Asthma / bronchospasm | peds | 50 mg/kg | IV | not captured | standing | pages 48, 119, 144 |
| Other | adult | 4 g | IV/IO | not captured | standing | pages 48, 139 |
| VF / pulseless VT | adult | 1–2 g | IV/IO | not captured | standing | page 48 |
Methylprednisolone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 125 mg | IV/IO | not captured | standing | page 28 |
| Allergic reaction | peds | 1–2 mg/kg | IV/IO | not captured | standing | page 28 |
| Other | adult | 125 mg | IV/IO | not captured | standing | page 28 |
| Other | adult | 125 mg | IV/IO | not captured | standing | page 28 |
| Other | peds | 1–2 mg/kg | IV/IO | not captured | standing | page 28 |
| Other | peds | 1–2 mg/kg | IV/IO | not captured | standing | page 28 |
Metoprolol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 5 mg | IV | not captured | standing | page 18 |
| Other | adult | 5 mg | IV | not captured | standing | page 18 |
Midazolam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 2–5 mg | IV/IO | not captured | standing | page 21 |
| Agitation | adult | 5–10 mg | IM/IN | not captured | standing | page 21 |
| Other | adult | 2–5 mg | IV/IO | not captured | standing | page 21 |
| Other | adult | 2–5 mg | IV/IO | not captured | standing | page 21 |
| Other | adult | 5–10 mg | IM/IN | not captured | standing | page 21 |
| Other | adult | 5–10 mg | IM/IN | not captured | standing | page 21 |
| Other | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 21 |
| Other | peds | 0.2 mg/kg | IM/IN | not captured | standing | page 21 |
| Post-intubation sedation | adult | 2–5 mg | IV/IO | not captured | standing | page 21 |
| Post-intubation sedation | adult | 5–10 mg | IM/IN | not captured | standing | page 21 |
Morphine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 2–10 mg | IV/IO/IM | not captured | standing | pages 54, 82, 109 |
| Mild to moderate pain | peds | 0.05–0.2 mg/kg | IV/IO/IM | not captured | standing | pages 54, 82, 109 |
Naloxone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.4 mg | IV/IO/IM/IN/SQ | not captured | standing | pages 50, 108 |
| Other | peds | 0.1 mg/kg | IV/IO/IM/IN/SQ | not captured | standing | pages 50, 108 |
Nitroglycerin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.4–0.8 mg | SL | not captured | standing | page 56 |
| Other | adult | 0.4–0.8 mg | not captured | not captured | standing | page 56 |
Norepinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypotension / shock | adult | 4 mcg | IV/IO | not captured | standing | pages 70, 126 |
| Other | adult | 4 mcg | IV/IO | not captured | standing | pages 70, 126 |
Olanzapine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 10 mg | IM | not captured | standing | page 15 |
| Agitation | peds | 5 mg | IM | not captured | standing | page 15 |
Ondansetron
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 4 mg | IV/IO/IM | not captured | standing | pages 13, 14 |
| Nausea / vomiting | adult | 8 mg | ODT | not captured | standing | page 13 |
| Nausea / vomiting | peds | 0.05–0.1 mg/kg | IV/IO/IM | not captured | standing | pages 13, 14 |
| Nausea / vomiting | peds | 4 mg | ODT | not captured | standing | page 13 |
P–R Pralidoxime, Prednisone, Promethazine, Rocuronium4
Pralidoxime
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Organophosphate poisoning | adult | 600 mg | IM | not captured | standing | page 111 |
Prednisone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 40–60 mg | PO | not captured | standing | page 29 |
Promethazine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 12.5 mg | IM | not captured | standing | page 11 |
| Nausea / vomiting | adult | 12.5–25 mg | IV | not captured | standing | page 11 |
Rocuronium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1.5 mg/kg | IV/IO | not captured | standing | page 60 |
S–Z Sodium Bicarbonate, Thiamine, Tranexamic Acid, Vasopressin4
Sodium Bicarbonate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | adult | 1 mEq/kg | IV/IO | not captured | standing | page 62 |
| Cardiac arrest | peds | 1 mEq/kg | IV/IO | not captured | standing | page 62 |
| Hyperkalemia | adult | 50 mEq | IV/IO | not captured | standing | page 157 |
| Tricyclic overdose | adult | 1 mEq/kg | IV/IO | not captured | standing | page 62 |
| Tricyclic overdose | peds | 1 mEq/kg | IV/IO | not captured | standing | page 62 |
Thiamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 100 mg | IV/IO/IM | not captured | standing | page 65 |
| Other | peds | 10–25 mg | IV/IO/IM | not captured | standing | page 65 |
Tranexamic Acid
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 2 g | IV/IO | not captured | standing | pages 67, 153, 158 |
Vasopressin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypotension / shock | adult | 0.01–0.04 unit | IV | not captured | standing | pages 71, 126 |
Cite this
Grant County, United States EMS Protocol Census. 178 dose entries, effective 2026-07-01.
https://protoquiz.com/census/agencies/grant-county/
The census is free and not for sale. Only public agencies are named.